Who Should Attend

From Pharmaceutical and Biotechnology companies with divisions or products for rare, genetic, or orphan diseases:

• Chief Medical Officers
• Medical Leads
• Vice Presidents, Directors, and Managers of:
• Market Access
• Commercialization
• Commercial Operations
• Commercial Insights / Analytics
• Market Insights / Analytics
• Pricing & Reimbursement
• Payer Relations
• Product / Portfolio Management
• Product Strategy
• New Product Planning
• Health Economics and Outcomes Research (HEOR)
• Medical Affairs
• Account Management
• Patient Advocacy / Relations
• Marketing
• Business Development

This Summit Also Benefits:

• Health Plans/Payers
• Pharmacies/PBMs
• Diagnostics Manufacturers
• Orphan Foundations/Associations
• Advocacy / Patient Groups
• Academia